Related Experiment Videos
Improved lung compliance following indomethacin therapy in premature infants with persistent ductus arteriosus
Insights
Early indomethacin treatment for premature infants with patent ductus arteriosus (PDA) significantly improved lung compliance (CL) and tidal volume (VT). This suggests a potentially better clinical outcome for these infants.
Area of Science:
- Neonatal Medicine
- Pediatric Cardiology
- Respiratory Physiology
Background:
- Patent ductus arteriosus (PDA) is a common condition in premature infants.
- PDA can lead to respiratory complications, including reduced lung compliance.
- Indomethacin is a medication used to close PDA.
Purpose of the Study:
- To evaluate the effect of intravenous indomethacin on dynamic lung compliance (CL) in premature infants with PDA.
- To assess changes in echocardiographic parameters and respiratory mechanics following indomethacin therapy.
Main Methods:
- A double-blind, controlled study involving 11 premature infants (6 control, 5 indomethacin).
- Dynamic lung compliance (CL) and tidal volume (VT) were measured.
- Echocardiography was used to assess left atrial/aortic root ratio (LA/Ao) and left ventricular end-diastolic dimension (LVEDD).
Main Results:
- Indomethacin group showed a significant decrease in LA/Ao and LVEDD.
- Indomethacin treatment led to a significant increase in tidal volume (VT) and lung compliance (CL).
- Control group exhibited no significant changes in these parameters.
Conclusions:
- Early indomethacin closure of PDA in premature infants improves dynamic lung compliance.
- Improved lung compliance may positively impact the clinical course and outcomes of premature infants with PDA.
- Indomethacin therapy offers a potential therapeutic benefit for respiratory function in this population.
Abstract:
In the course of a double-blind controlled study of intravenous indomethacin therapy in premature infants with patent ducts arteriosus (PDA), dynamic lung compliance (CL) was determined in 11 infants (six control, five indomethacin) who were not on assisted ventilation during the study period. The clinical, biochemical and laboratory data before the study were comparable between the groups. Following therapy with indomethacin there was a significant decrease in left atrial/aortic root ratio (LA/Ao), left ventricular end-diastolic dimension (LVEDD) on echocardiogram, and an increase in tidal volume (VT) and CL. In the control group, these variables did not change significantly. The improved lung compliance following early indomethacin closure of PDA may alter the clinical course and outcome of these premature infants.